THREE TNF-A-INHIBITORS FOR TREATMENT OF RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS

被引：0
|
作者：
Ivakhnenko, O. [1 ]
Rebrova, O. [2 ]
Avxentyeva, M. [3 ]
Khachatryan, G. [1 ]
机构：
[1] Autonomous Nonprofit Org, Natl Ctr Hlth Technol Assessment, Moscow, Russia
[2] Pirogov Russian Natl Res Med Univ, Moscow, Russia
[3] Russian Presidential Acad Natl Econ & Publ Adm, Moscow, Russia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1498
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A564 / A564
页数：1
相关论文
共 50 条
  • [1] Discontinuation of Methotrexate or TNF Inhibitors in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    George, Michael D.
    Baker, Joshua F.
    Ogdie, Alexis
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [2] Golimumab In the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Oldfield, Vicki
    Plosker, Greg L.
    BIODRUGS, 2009, 23 (02) : 125 - 135
  • [3] GolimumabIn the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Vicki Oldfield
    Greg L. Plosker
    BioDrugs, 2009, 23 : 125 - 135
  • [4] Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
    Rossini, M.
    Viapiana, O.
    Orsolini, G.
    Fracassi, E.
    Idolazzi, L.
    Gatti, D.
    Adami, S.
    Govoni, M.
    REUMATISMO, 2014, 66 (04) : 285 - 303
  • [5] PERSISTENCY WITH SUBCUTANEOUS ANTI-TNF THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
    Tandon, N.
    Haas, S.
    Waters, H.
    Olson, W.
    Bolge, S.
    Gunnarsson, C.
    VALUE IN HEALTH, 2012, 15 (04) : A41 - A41
  • [6] Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study
    Rotar, Ziga
    Svetina, Petra
    Tomsic, Matija
    Hocevar, Alojzija
    Prapotnik, Sonja
    BMJ OPEN, 2020, 10 (02):
  • [7] Golimumab: a new anti-TNF-α agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    Voulgari, Paraskevi V.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 721 - 733
  • [8] Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
    Poddubnyy, Denis
    Rudwaleit, Martin
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (04) : 655 - 673
  • [9] METHOTREXATE AND ANTI-TNF TREATMENT IMPROVE ENDOTHELIAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Deyab, G.
    Hokstad, I.
    Smastuen, M. C.
    Agewall, S.
    Hollan, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 704 - 704
  • [10] Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors
    Kathleen Tymms
    Geoff Littlejohn
    Hedley Griffiths
    Julien de Jager
    Paul Bird
    Fred Joshua
    Peter Nash
    Malcolm Handel
    Hamish McManus
    Belinda E. Butcher
    Peter Youssef
    Clinical Rheumatology, 2018, 37 : 1617 - 1623
12345